Additive formulation for reduction or prevention of microbially induced corrosion in concrete or cementitious material
A formulation including a material that is in a wet-state in which the material is an uncured concrete, an uncured cementitious material, or a combination thereof, a Quat Silane that cures on and/or within the material, a fungicide, and a defoamer.
1. A formulation comprising:
a material that is in a wet-state in which the material is an uncured concrete, an uncured cementitious material, or a combination thereof,
a Quat Silane that cures on and/or within the material,
a fungicide selected from the group consisting of Sodium OrthophenylPhenol, Imazalil Sulphate, diiodomethyl-p-tolylsulfone, carbamate, isothiazolinone, azole, chlorothalonil, zinc pyrithione, copper pyrithione, sodium pyrithione, and a combination thereof,
a defoamer from about 2 weight % to about 25 weight % of the amount of the Quat Silane in the formulation,
wherein the ratio of the Quat Silane to the fungicide in the formulation is in a range of about 5:1 to about 1:5.
2. The formulation according to claim 1 , wherein the defoamer is selected from the group consisting of polyether amine, ethoxylated alcohol, silicone-based defoamer, tributyl phosphate, and a combination thereof.
3. The formulation according to claim 1 , wherein the carbamate is selected from the group consisting of Iodopropynyl butylcarbamate (IPBC), carbendazim, and a combination thereof.
4. The formulation according to claim 1 , wherein the isothiazolinone is selected from the group consisting of OIT (2-Octyl-2H-isothiazol-3-one), DCOIT (4,5-Dichloro-2-octyl-4-isothiazolin-3-one), BBIT (N-butyl-1, 2-benzisothiazolin-3-one), and a combination thereof.
5. The formulation according to claim 1 , wherein the azole is selected from the group consisting of tebuconazole and propiconazole, and a combination thereof.
6. The formulation according to claim 1 , wherein the Quat Silane is present at an effective amount to reduce bacteria and fungus in the material prior to curing.
7. The formulation according to claim 2 , wherein the carbamate is selected from the group consisting of Iodopropynyl butylcarbamate (IPBC), carbendazim, and a combination thereof.
8. The formulation according to claim 7 , wherein the isothiazolinone is selected from the group consisting of OIT (2-Octyl-2H-isothiazol-3-one), DCOIT (4,5-Dichloro-2-octyl-4-isothiazolin-3-one), BBIT (N-butyl-1, 2-benzisothiazolin-3-one), and a combination thereof.
9. The formulation according to claim 8 , wherein the azole is selected from the group consisting of tebuconazole and propiconazole, and a combination thereof.
10. The formulation according to claim 9 , wherein the Quat Silane is present at an effective amount to reduce bacteria and fungus in the material prior to curing.